Delivery Order SPE2DB20D3103-SPE2DB25FQ0L7
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,438.62 to AmerisourceBergen Drug Corp for Advair HFA 115-21 mcg inhalers (12 grams) on September 15, 2025, with completion expected by September 16, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award to this established pharmaceutical distributor. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,260.90 to AmerisourceBergen Drug Corp for Advair HFA 45-21 mcg inhalers (12 grams) with an ultimate completion date of September 19, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded through an open procurement process. The pharmaceutical product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Advair HFA 115-21 micrograms inhaler in 12-gram units, valued at $9,119.12. The award is a firm fixed price delivery order with an ultimate completion date of August 6, 2025, and carries no set-aside designation, indicating it was awarded through open competition. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will fulfill this order from its...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,517.23 to AmerisourceBergen Drug Corp for Advair HFA 115-21 mcg inhaler (12 grams) on June 18, 2025, with an ultimate completion date of June 20, 2025. This firm fixed-price delivery order represents a non-competitive set-aside award and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a...
- The Defense Logistics Agency awarded a delivery order valued at $1,385.34 to AmerisourceBergen Drug Corp for Advair HFA 115-21 mcg inhalers (12 grams) on August 1, 2025, with a completion date of August 4, 2025. This firm fixed price delivery order represents a non-set-aside competitive award and is being performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,775.70 to AmerisourceBergen Drug Corp for Advair HFA 230-21 mcg inhalers (12 gm) on May 8, 2025, with an ultimate completion date of May 9, 2025. This firm fixed-price delivery order represents a non-competitive award and will be fulfilled at the contractor's corporate office location in Conshohocken, Pennsylvania. The award is issued as a child contract under AmerisourceBergen's larger indefinite delivery contract (IDC)...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,766.80 to AmerisourceBergen Drug Corp for Advair HFA 115-21 mcg inhalers (12 grams) on September 3, 2025, with an ultimate completion date of September 4, 2025. This firm fixed price delivery order was competitively awarded without a set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a small-value transaction within the...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Advair HFA 230-21 mcg inhalers (12 gm) valued at $4,403.25. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The contract is set to conclude by August 20, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls...
- The Defense Logistics Agency awarded a delivery order valued at $2,353.70 to AmerisourceBergen Drug Corp for Advair HFA 115-21 micrograms inhaler (12-gram units) on June 27, 2025, with a completion date of June 30, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a routine pharmaceutical supply transaction under the company's existing contract vehicle. The work will be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Advair HFA 115-21 micrograms inhalers (12-gram units) with a ceiling value of $2,208.80. This is a firm fixed price delivery order with no set-aside designation, issued under competitive procurement procedures. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 19,...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB25FQ0L7Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Advair HFA 115-21 mcg inhalers (12 gram units) valued at $1,139.92. This competitive, non-set-aside delivery order was issued on August 27, 2025, with an ultimate completion date of August 28, 2025, and employs firm fixed pricing. The award is executed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical supply vehicle running through December 2026. AmerisourceBergen serves as a prime vendor for military healthcare systems, providing a comprehensive range of pharmaceutical products and medical supplies across multiple therapeutic domains. As a major pharmaceutical distributor and critical federal medical procurement vendor, the company fulfills recurring supply requirements for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems, with this particular order supporting respiratory medication needs for federal healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 8/27/25 |